AstraZeneca announces SYMBICORT is now available in the US
...U.S. The addition of SYMBICORT to our respiratory portfolio reinforces AstraZenecas commitment to developing new, effective treatments, and provides patients and physicians with a new treatment option to improve and maintain lung health. SYMBICORT was approved by the U.S. Food and Drug Administration (FDA) ...Elsevier partners with Rice Science
...tnership enhances our well-established agriculture portfolio and has been the result of close collaboration with colleagues in our Beijing office and with representatives of the China National Rice Research Institute, to achieve our shared goal to extend the global reach and visibility of Rice Science. ...The Clorox company's new personal care product lends a hand
... Anywhere Hand Sanitizing Spray expands the Clorox portfolio to include both hand and surface solutions that help create a healthier environment, reinforcing Cloroxs nearly 100-year legacy as a leading producer of sanitizing products. Hands Down, Hand Hygiene is Mission-Critical Effective hand hygiene is...Latest IPCC report highlights need for integrated climate/human behavior models
...policy options are complementary tools in a policy portfolio designed to reduce climate risk by reducing exposure (through mitigation) and reducing sensitivity to climate impacts (through adaptation)." ...LIALDA -- the first oral once-daily mesalamine for ulcerative colitis -- now available
...erative colitis, which complements our existing GI portfolio and reinforces our commitment to improving the treatment of gastrointestinal diseases." "Although not everyone's experience is the same, taking the pills for my disease seemed to consume my life - my next dosage was constantly on my mind," said Bec...ESA contribution to International Polar Year 2007-2008
...ilable through an extensive Earth observation data portfolio containing current and historical data (dating back 15 years) from its ERS 1, ERS 2 and Envisat satellites, as well as data collected from a number of non-ESA satellites. Moreover, during this two-year period, ESA has committed to helping scientis...Springer and the Royal Academy of Medicine of Ireland enter into publishing partnership
... 2007. The addition of this journal to Springer's portfolio accentuates its growing strength in medical publishing. Established in 1832, the Irish Journal of Medical Science is one of the first and foremost scientific journals in the Anglo-Celtic islands. With articles written by international specialists, i...Wiley acquires HEED, the world's leading Health Economic Evaluations Database
...on strengthens Wiley's burgeoning health economics portfolio and will help create numerous synergies, including raising Wiley's profile in the health economics market, especially in the U.K." Gerry Crosbie, Managing Director of HEED, said, "I'm excited and pleased at the prospect of working with the team at W...Rockefeller Foundation will not abandon its commitments to public health
...hat talk of health's erasure from the Foundation's portfolio is simply wrong. This news is welcome, and counters a damaging year of uncertainty and speculation. While she and her team could have done more to bring the health community with them during this interval of change, the promise, at least, is that hea...Satellites help ensure safe sunning
...incorporating the public health aspects within its portfolio of services....Access to science enhanced by new NIH-ASH agreement
... help achieve NIH's goals of managing its research portfolio and developing a digital research archive, and protect the integrity of journal articles while maintaining the publisher embargo period of up to 12 months. "ASH is pleased to have worked closely with NIH to reach an agreement on this issue," said K...Wiley expands partnership with Skyscape
...ship with Wiley by adding InfoPOEMs to our growing portfolio of trusted resources," said Sandeep Shah, President & CEO of Skyscape. "For more than a decade, Skyscape has helped medical professionals get up-to-the-minute access to accurate information to help them provide better care at lower costs, while savin...Why we need better estimates of global demand for an HIV vaccine
...sure adequate production capacity guiding research portfolio management decisions by highlighting how vaccine characteristics may affect demand guiding governments in planning their HIV vaccination programs....EMCare now available via Dialog and Datastar
.... EMCare is the most recent addition to Elsevier's portfolio of bibliographic databases, and with close to 2 million records from the nursing, allied health and biomedical literature, it is a key information resource for professionals engaged at all levels of healthcare, whether in patient care, scientific res...NIAID announces leadership for newly restructured HIV/AIDS clinical trials networks
...utes of Health (NIH), supports the world's largest portfolio of clinical HIV/AIDS research. "The new network structure expands our clinical research capacity and strengthens our ability to take advantage of emerging scientific opportunities," says NIAID Director Anthony S. Fauci, M.D. "By creating a more in...Stevens in agreement with Competitive Technologies to commercialize Stevens' IP worldwide
... a growing relationship with CTT. Stevens' rich IP portfolio reflects our educational environment of enterprise...nologies and we look forward to adding them to our portfolio and bringing them to market," commented Mike Kiley, CTT's Executive VP and Chief Technology Officer....Springer acquires Obesity Surgery from FD-Communications
...ented, "Obesity Surgery significantly enhances our portfolio of surgery journals. The purchase of this prestigious publication is a clear indication that Springer's strategy of acquiring high-quality content is solidly on track." He added, "Springer will provide the infrastructure needed not only to ensure r...Shire's DAYTRANA(TM) transdermal patch approved by FDA for treatment of ADHD
...thew Emmens. "The addition of DAYTRANA to Shire's portfolio reaffirms our position as the market leader in ADHD." Shire and Noven Pharmaceuticals, Inc. submitted an amended New Drug Application (NDA) for DAYTRANA to the FDA in June of last year. DAYTRANA is licensed globally to Shire by Noven and will be av...Takeda submits new drug application for extended-release type 2 diabetes medication, ACTOplus met
...tainly proud of this NDA submission, and the ACTOS portfolio of products," said John Yates, M.D., president of TGR&D. "Not all patients are alike, especially in diabetes, and the addition of this new product would provide patients and their physicians with more options and greater flexibility, while continuin...